Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 92 (2) , 208-217
- https://doi.org/10.1093/bja/aeh042
Abstract
Descriptions of the pharmacokinetics and metabolism of morphine and its metabolites in young children are scant. Previous studies have not differentiated the effects of size from those related to age during infancy. Postoperative children 0-3 yr old were given an intravenous loading dose of morphine hydrochloride (100 micro g kg(-1) in 2 min) followed by either an intravenous morphine infusion of 10 micro g h(-1) kg(-1) (n=92) or 3-hourly intravenous morphine boluses of 30 micro g kg(-1) (n=92). Additional morphine (5 micro g kg(-1)) every 10 min was given if the visual analogue (VAS, 0-10) pain score was >/=4. Arterial blood (1.4 ml) was sampled within 5 min of the loading dose and at 6, 12 and 24 h for morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). The disposition of morphine and formation clearances of morphine base to its glucuronide metabolites and their elimination clearances were estimated using non-linear mixed effects models. The analysis used 1856 concentration observations from 184 subjects. Population parameter estimates and their variability (%) for a one-compartment, first-order elimination model were as follows: volume of distribution 136 (59.3) litres, formation clearance to M3G 64.3 (58.8) litres h(-1), formation clearance to M6G 3.63 (82.2) litres h(-1), morphine clearance by other routes 3.12 litres h(-1) per 70 kg, elimination clearance of M3G 17.4 (43.0) litres h(-1), elimination clearance of M6G 5.8 (73.8) litres h(-1). All parameters are standardized to a 70 kg person using allometric 3/4 power models and reflect fully mature adult values. The volume of distribution increased exponentially with a maturation half-life of 26 days from 83 litres per 70 kg at birth; formation clearance to M3G and M6G increased with a maturation half-life of 88.3 days from 10.8 and 0.61 litres h(-1) per 70 kg respectively at birth. Metabolite formation decreased with increased serum bilirubin concentration. Metabolite clearance increased with age (maturation half-life 129 days), and appeared to be similar to that described for glomerular filtration rate maturation in infants. M3G is the predominant metabolite of morphine in young children and total body morphine clearance is 80% that of adult values by 6 months. A mean steady-state serum concentration of 10 ng ml(-1) can be achieved in children after non-cardiac surgery in an intensive care unit with a morphine hydrochloride infusion of 5 micro g h(-1) kg(-1) at birth (term neonates), 8.5 micro g h(-1) kg(-1) at 1 month, 13.5 micro g h(-1) kg(-1) at 3 months and 18 micro g h(-1) kg(-1) at 1 year and 16 micro g h(-1) kg(-1) for 1- to 3-yr-old children.Keywords
This publication has 38 references indexed in Scilit:
- Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infantsBritish Journal of Anaesthesia, 2003
- Hormonal and metabolic stress responses after major surgery in children aged 0–3 years: a double-blind, randomized trial comparing the effects of continuous versus intermittent morphine †British Journal of Anaesthesia, 2001
- The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3-year-old infantsPAIN®, 2000
- Glucuronidation in HumansClinical Pharmacokinetics, 1999
- Clearance of Morphine in Postoperative Infants During Intravenous InfusionAnesthesia & Analgesia, 1998
- Systematic review of factors affecting the ratios of morphine and its major metabolitesPain, 1998
- Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric PatientsClinical Pharmacokinetics, 1997
- Recommended use of morphine in neonates, infants and children based on a literature review: Part 1—PharmacokineticsPediatric Anesthesia, 1997
- A Size Standard for PharmacokineticsClinical Pharmacokinetics, 1996
- Morphine glucuronidation in human fetal and adult liverEuropean Journal of Clinical Pharmacology, 1982